ARTICLES

Take a look at our latest articles, providing insight on the latest topics across the pharmaceutical landscape.

Unlocking the Future of Rare Disease Care: The Promise of AI

Unlocking the Future of Rare Disease Care: The Promise of AI

We’ve seen the rise and fall of many trends in healthcare innovation—but AI in rare disease care could be a turning point. AI has been part of medicine since the 1970s, but only now does it have the power to truly transform care—especially for rare diseases, where...

ASCO 2025: A Behavioral Lens on Innovation

ASCO 2025: A Behavioral Lens on Innovation

ASCO 2025 marked a pivotal moment in oncology, emphasizing a powerful shift to patient-centered, equitable, and behaviorally-informed care. Underscoring the human side of cancer treatment, it reflected a community committed to truly transforming patient outcomes....

Harnessing the power of AI securely, ethically and responsibly

Harnessing the power of AI securely, ethically and responsibly

Today, the use of Artificial Intelligence (AI) has become habitual to almost the entire workforce and population. It has become an incredibly potent asset to the healthcare industry, aiding greater efficacy in data analysis of clinical trials, diagnostic testing and...

Using AI to identify how to optimise a CVA

Using AI to identify how to optimise a CVA

THE CHALLENGE Operating in an established, highly competitive space is a challenge for any brand – how do you make your brand stand out and drive the behaviour change you desire? Our client faced this exact challenge with two core customer segments, one of which...

Breaking cultural stigma around illnesses in Asia

Breaking cultural stigma around illnesses in Asia

This article explores the impact of cultural influences and stigma on healthcare in the Asia-Pacific region. It examines how cultural stigma affects disease management and offers best practices to reduce stigma, promoting a more inclusive and supportive healthcare...

Brand building: pharma’s billion-dollar blind spot

Brand building: pharma’s billion-dollar blind spot

15 seconds  That’s all you have, everyday as a marketer.  15 seconds is the maximum amount of time a cognitively overloaded HCP will spend considering prescribing your brand in a live situation. That makes those 15 seconds everything to pharma marketing teams – and to...

Take the pain out of brand planning

Take the pain out of brand planning

Brand planning season is upon us, and for many teams, it can feel like an overwhelming process filled with complex templates, endless revisions, and cross-functional challenges.   However, brand planning doesn’t have to be painful. By focusing on ambition,...

Discover metAInsights™

Learn about our AI-powered research assistant

Learn More Later